Arkansas Children's Hospital
Locations
Transplant Summary
Overview
Arkansas Children’s Hospital offers both allogeneic autologous blood marrow transplants to treat cancers, immune disorders and blood diseases. BMT uses healthy bone marrow, or stem cells to replace damaged or destroyed bone marrow. Our autologous program is accredited by the internationally recognized Foundation for the Accreditation of Cellular Therapy (FACT). Our program is also a certified CAR-T site. Chimeric antigen receptor (CAR) T cells uses the patient’s own genetically modified T cells to attack and kill cancer cells. This therapy is used to treat some of the most challenging pediatric cancers including B-cell acute lymphoblastic leukemia (ALL). We are currently using CAR-T cells treatment known as tisagenlecleucel (Kymriah).
This center has been an NMDP transplant center since August 2024.
Attending physicians
Pediatric - Laruen Appell, Jason Farrar, Arunkumar Modi
Transplants performed
Marrow/PBSC onlyCord blood transplants
Not performedPatient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 13 patients.The actual 1-year survival of these patients is 92.3%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 63.7% and 100%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total pediatric transplants
35
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow7PBSC4Cord blood0Total11Unrelated donorMarrow11PBSC2Cord blood0Total13Total allogeneicMarrow18PBSC6Cord blood0Total24AutologousMarrowBoth marrow & PBSC 11PBSC—Cord blood—Total11Total combinedMarrowBoth marrow & PBSC 35PBSC—Cord blood0Total35All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-181019-44145-64065+0Total11Unrelated 0-181219-44145-64065+0Total13Autologous 0-18919-44245-64065+0Total11Total 0-183119-44445-64065+0Total35Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Arkansas Children’s Hospital BMT Survivorship Program
1 Children's Way Little Rock, AR 72202 Phone:(501) 392-8501 Physician Referrals:(501) 364-3160 For more information about this program: https://www.archildrens.org/programs-and-services/cancer-and-blood-disorders/treatments/blood-marrow-transplant-and-cellular-therapy (Opens in a new tab)Overview
Arkansas Children’s Hospital BMT survivorship program is a comprehensive care program for persons who received BMT and cellular therapy as a child. We have multidisciplinary team and range of subspecialties who work in close collaboration to provide care needed for our unique patient population. We accept patients up to age 21 years regardless of their diagnosis and location of transplant center.
Staff
Program Director:Lauren Appell, MDProgram Coordinator:Traci Hackler, RNMedical Specialties in Program
Allergy/immunology, cardiology, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, Medical Genetics, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, telemedicine, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Children- Allogeneic and Autologous transplant recipients
- 2 years after transplant.
- Patients who were transplanted as a child at this center up to age 21 years
- Does accept patients who were transplanted at another hospital
- Will admit pediatric patients who transferred into the program if they are under age 21